BHRB Stock Analysis: Burke & Herbert Financial | NASDAQ
Banks - Regional | NASDAQ, USA | Market Cap: 1.433m USD | 12M Return: 17.1% | US12135Y1082 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 8.29M
EPS Trend: 86.2%
Qual. Beats: 0
Rev. Trend: 85.0%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Burke & Herbert Financial Services Corp. (BHRB) is a bank holding company that operates Burke & Herbert Bank & Trust Company, a community bank offering consumer and commercial deposit products-including checking, money market, savings accounts, and certificates of deposit-alongside a broad lending portfolio spanning commercial real estate, residential mortgages, commercial and industrial loans, and consumer credit.
In addition to traditional banking, the company provides digital and mobile banking, cash management, treasury management, merchant services, and wealth and trust services for both retail and small business customers. Founded in 1852, the bank is headquartered in Alexandria, Virginia, and is classified within the regional banks sub-industry of the financials sector, serving primarily the Mid-Atlantic community banking market.
- Net interest margin compression pressures profitability as rates decline
- CRE loan concentration draws heightened regulatory scrutiny
- Deposit costs rise amid intense regional banking competition
| Net Income: 103.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -0.99 > 1.0 |
| NWC/Revenue: -1.49k% < 20% (prev -1.27k%; Δ -222.9% < -1%) |
| CFO/TA 0.01 > 3% & CFO 100.0m > Net Income 103.5m |
| Net Debt (-1.31b) to EBITDA (155.7m): -8.42 < 3 |
| Current Ratio: 0.23 > 1.5 & < 3 |
| Outstanding Shares: last quarter (20.3m) vs 12m ago 34.29% < -2% |
| Gross Margin: 68.64% > 18% (prev 67.74%; Δ 0.90% > 0.5%) |
| Asset Turnover: 5.19% > 50% (prev 6.18%; Δ -0.98% > 0%) |
| Interest Coverage Ratio: 0.83 > 6 (EBIT TTM 127.8m / Interest Expense TTM 153.1m) |
| A: -0.67 (Total Current Assets 2.14b - Total Current Liabilities 9.48b) / Total Assets 11.0b |
| B: 0.05 (Retained Earnings 558.8m / Total Assets 11.0b) |
| C: 0.01 (EBIT TTM 127.8m / Avg Total Assets 9.46b) |
| D: 0.12 (Book Value of Equity 1.15b / Total Liabilities 9.88b) |
| Altman-Z'' = -3.99 = D |
| DSRI: 1.36 (Receivables 48.7m/35.4m, Revenue 491.2m/487.2m) |
| GMI: 0.99 (GM 67.74% / 68.64%) |
| AQI: 0.88 (AQ_t 0.79 / AQ_t-1 0.90) |
| SGI: 1.01 (Revenue 491.2m / 487.2m) |
| TATA: 0.00 (NI 103.5m - CFO 100.0m) / TA 11.0b) |
| Beneish M = -2.80 (Cap -4..+1) = A |
As of November 20, 2026, the stock is trading at USD 68.46 with a total of 134,423 shares traded. Over the past week, the price has changed by -3.52%, over one month by -0.14%, over three months by -2.69% and over the past year by +17.14%.
Current recommended Stop Loss: 66.20 (which is 3.3% or 1.3 ATR below the current price).
Burke & Herbert Financial has received a consensus analysts rating of 4.25. Therefore, it is recommended to buy BHRB.
- StrongBuy: 2
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 79.8 | 16.5% |
P/E Trailing = 11.8696
P/S = 3.6355
P/B = 1.2591
Revenue TTM = 491.2m USD
EBIT TTM = 127.8m USD
EBITDA TTM = 155.7m USD
Long Term Debt = 251.4m USD (from longTermDebt, last quarter)
Short Term Debt = 525.0m USD (from shortTermDebt, last quarter)
Debt = 776.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.31b USD (calculated: Debt 776.4m - CCE 2.09b)
Enterprise Value = 122.2m USD (1.43b + Debt 776.4m - CCE 2.09b)
Interest Coverage Ratio = 0.83 (Ebit TTM 127.8m / Interest Expense TTM 153.1m)
EV/FCF = 1.31x (Enterprise Value 122.2m / FCF TTM 93.3m)
FCF Yield = 76.39% (FCF TTM 93.3m / Enterprise Value 122.2m)
FCF Margin = 19.00% (FCF TTM 93.3m / Revenue TTM 491.2m)
Net Margin = 21.07% (Net Income TTM 103.5m / Revenue TTM 491.2m)
Gross Margin = 68.64% ((Revenue TTM 491.2m - Cost of Revenue TTM 154.0m) / Revenue TTM)
Gross Margin QoQ = 70.25% (prev 58.30%)
Tobins Q-Ratio = 0.01 (Enterprise Value 122.2m / Total Assets 11.0b)
Interest Expense / Debt = 19.72% (Interest Expense 153.1m / Debt 776.4m)
Taxrate = 19.03% (24.3m / 127.8m)
NOPAT = 103.5m (EBIT 127.8m * (1 - 19.03%))
Current Ratio = 0.23 (Total Current Assets 2.14b / Total Current Liabilities 9.48b)
Debt / Equity = 0.67 (Debt 776.4m / totalStockholderEquity, last quarter 1.15b)
Debt / EBITDA = -8.42 (Net Debt -1.31b / EBITDA 155.7m)
Debt / FCF = -14.05 (Net Debt -1.31b / FCF TTM 93.3m)
Total Stockholder Equity = 1.02b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.09% (Net Income 103.5m / Total Assets 11.0b)
RoE = 10.15% (Net Income TTM 103.5m / Total Stockholder Equity 1.02b)
RoCE = 10.06% (EBIT 127.8m / Capital Employed (Equity 1.02b + L.T.Debt 251.4m))
RoIC = 5.04% (NOPAT 103.5m / Invested Capital 2.05b)
WACC = 10.45% (E(1.43b)/V(2.21b) * Re(7.47%) + D(776.4m)/V(2.21b) * Rd(19.72%) * (1-Tc(0.19)))
Discount Rate = 7.47% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 78.57 | Cagr: 55.40%
[DCF] Terminal Value 65.66% ; FCFF base≈113.9m ; Y1≈99.9m ; Y5≈80.7m
[DCF] Fair Price = 112.6 (EV 963.6m - Net Debt -1.31b = Equity 2.27b / Shares 20.2m; r=10.45% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 86.16 | EPS CAGR: 46.02% | SUE: 0.76 | # QB: 0
Revenue Correlation: 84.95 | Revenue CAGR: 49.98% | SUE: 0.76 | # QB: 0
EPS current Quarter (2027-03-31): EPS=2.12 | Chg30d=+0.00% | Revisions=+0% | Analysts=3
EPS current Year (2026-12-31): EPS=6.15 | Chg30d=-10.17% | Revisions=-40% | GrowthEPS=-20.4% | GrowthRev=+26.6%
EPS next Year (2027-12-31): EPS=8.68 | Chg30d=-0.80% | Revisions=+0% | GrowthEPS=+8.6% | GrowthRev=+11.4%
[Analyst] Revisions Ratio: -22% (up=2, down=4)